Prevalence, antimicrobial susceptibility, and genetic diversity of Pseudomonas aeruginosa as intestinal colonizer in the community

Infectious Diseases

Volumn 47, Issue 9, 2015, Pages 654-657

  Valenza, Giuseppe ^a   Tuschak, Christian ^b   Nickel, Silke ^a   Krupa, Elzbieta ^b   Lehner Reindl, Verena ^a   Höller, Christiane ^b  

^a Bavarian Health and Food Safety Authority   (Germany)

^b Bavarian Health and Food Safety Authority   (Germany)

Author keywords

Antimicrobial susceptibility; Community; Genetic diversity; Intestinal carriage; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD; DISK DIFFUSION; FECES ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INTESTINE; MALE; MICROBIAL COMMUNITY; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; FECES; GENETICS; GERMANY; HETEROZYGOTE; INFANT; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PSEUDOMONAS INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; INTESTINES; MALE; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84957411828     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.3109/23744235.2015.1031171     Document Type: Article

References (11)

1. Stoodley BJ, Thom BT. Observations on the intestinal carriage of Pseudomonas aeruginosa. J Med Microbiol 1970; 3: 367-75.
2. Markou P, Apidianakis Y. Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer. Front Cell Infect Microbiol 2014; 7: 115.
3. Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013; 57: 1488-95.
4. Edelstein MV, Skleenova EN, Shevchenko OV, D'souza JW, Tapalski DV, Azizov IS, et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis 2013; 13: 867-76.
5. van Mansfeld R, Willems R, Brimicombe R, Heijerman H, van Berkhout FT, Wolfs T, et al. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J Clin Microbiol 2009; 47: 4096-101.
6. Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, et al. Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 2014; 58: 1228-30.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S19. CLSI; 2010.
8. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004; 42: 5644-9.
9. Gomila M, Del Carmen Gallegos M, Fernández-Baca V, Pareja A, Pascual M, Díaz-Antolín P, et al. Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain. BMC Microbiol 2013; 13: 138.
10. Koutsogiannou M, Drougka E, Liakopoulos A, Jelastopulu E, Petinaki E, Anastassiou ED, et al. Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital. J Clin Microbiol 2013; 51: 665-8.
11. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Gerharz H, et al. Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect 2010; 16: 1494-500.